|
Volumn 24, Issue 1, 2005, Pages 82-86
|
External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA FETOPROTEIN;
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
EPIRUBICIN;
MITOMYCIN;
ADULT;
AGED;
ARTICLE;
BLOOD;
CHEMOEMBOLIZATION;
CLINICAL TRIAL;
FEMALE;
HUMAN;
LIVER CELL CARCINOMA;
LIVER TUMOR;
MAGNETIC AND ELECTROMAGNETIC EQUIPMENT;
MALE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADULT;
AGED;
ALPHA-FETOPROTEINS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, HEPATOCELLULAR;
CHEMOEMBOLIZATION, THERAPEUTIC;
COMBINED MODALITY THERAPY;
EPIRUBICIN;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
MITOMYCIN;
PARTICLE ACCELERATORS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 33645254695
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (0)
|